Conventional vaccination methods: Inactivated and live attenuated vaccines T Andey, S Soni, S Modi Advanced Vaccination Technologies for Infectious and Chronic Diseases, 37-50, 2024 | 5 | 2024 |
History of Nanoparticles KL Jetha, A Vyas, D Teli, A Chaudhari, R Satasiya, V Patel, S Soni, ... Nanocarrier Vaccines: Biopharmaceutics‐Based Fast Track Development, 1-23, 2024 | 3 | 2024 |
Piperlongumine in combination with EGFR tyrosine kinase inhibitors for the treatment of lung cancer cells SR Modi, T Andey Oncology Research 32 (11), 1709, 2024 | 1 | 2024 |
Gene expression changes in COVID-19 patients impact pathways related to circadian rhythm, phosphatidylinositol signaling, cytokine storm, and platelet aggregation S Modi, N Gandhi, H Yoon, J Kuack, H Jee, C Enwere, O Iskarous, ... Gene Reports 33, 101831, 2023 | 1 | 2023 |
Modular self-emulsifying drug delivery platform to enhance cellular uptake activity in triple-negative breast cancer N Gandhi, S Modi, S Soni, T Andey European Journal of Pharmaceutical Sciences 206, 106993, 2025 | | 2025 |
Overcoming Tumor Resistance to Gefitinib and Erlotinib in Non-Small Cell Lung Cancer Using Piperlongumine TA Andey, S Modi American Journal of Pharmaceutical Education 88 (9), 2024 | | 2024 |
Investigation of the antipoliferative effect of the Xylopia Aethiopicaextract in triple-negative breast cancer cells S Soni, SR Modi, T Andey Cancer Research 84 (6_Supplement), 551-551, 2024 | | 2024 |
NFE2L3 regulates the expression of BHLHE40 in triple-negative breast cancer SR Modi, T Andey, G Acquaah-Mensah Cancer Research 84 (6_Supplement), 4883-4883, 2024 | | 2024 |
The role of master regulators such as HMGA1, SOX9, FOXA1 in the development of triple‐negative breast cancer SR Modi, T Andey, G Acquaah‐Mensah The FASEB Journal 36, 2022 | | 2022 |
CYANOACRYLATES: AN OVERVIEW IN ITS APPLICATION AS A TISSUE ADHESIVE H Kathpalia, V Prabhu, S Modi | | |
EVALUATION OF PHARMACOLOGICAL ACTIONS OF DERIVATIVES OF 4-THIAZOLIDIONES AND 1, 3, 4-THIADIAZOLES S Modi, G Aggarwal | | |